SEC Filing Details

Document Details

Form
Filing Date
10-31-2022
Document Date
10-21-2022
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Taysha Gene Therapies
Issuer
TAYSHA GENE THERAPIES, INC.
Scroll to top